Clostridioides difficile colonization and the frequency of subsequent treatment for C. difficile infection in critically ill patients
Infection Control & Hospital Epidemiology · 2023
DOI: 10.1017/ice.2022.240 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Infection Control & Hospital Epidemiology, 2023. Verfasst von Erica L MacKenzie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of Infectious Diseases & Global Health, The University of Chicago Medicine, Chicago, Illinois. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To determine risk factors for Clostridioides difficile colonization and C. difficile infection (CDI) among patients admitted to the intensive care unit (ICU).
Design
Retrospective observational cohort study.
Setting
Tertiary-care facility. Patients: All adult patients admitted to an ICU from July 1, 2015, to November 6, 2019, who were tested for C. difficile colonization. Patients with CDI were excluded.
Methods
Information was collected on patient demographics, comorbidities, laboratory results, and prescriptions. We defined C. difficile colonization as a positive nucleic acid amplification test for C. difficile up to 48 hours before or 24 hours after intensive care unit (ICU) admission without evidence of active infection. We defined active infection as the receipt of an antibiotic whose only indication is the treatment of CDI. The primary outcome measure was the development of CDI up to 30 days after ICU admission. Logistic regression was used to model associations between clinical variables and the development of CDI.
Results
The overall C. difficile colonization rate was 4% and the overall CDI rate was 2%. Risk factors for the development of CDI included C. difficile colonization (aOR, 13.3; 95% CI, 8.3–21.3; P < .0001), increased ICU length of stay (aOR, 1.04; 95% CI, 1.03–1.05; P < .0001), and a history of inflammatory bowel disease (aOR, 3.8; 95% CI, 1.3–11.1; P = .02). Receipt of any antibiotic during the ICU stay was associated with a borderline increased odds of CDI (aOR, 1.9; 95% CI, 1.0–3.4; P = .05).
Conclusion
C. difficile colonization is associated with the development of CDI among ICU patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Section of Infectious Diseases & Global Health, The University of Chicago Medicine, Chicago, Illinois.
- Department of Infection Control and Prevention, The University of Chicago Medicine, Chicago, Illinois.
- Department of Pediatrics, Section of Infectious Diseases, The University of Chicago Medicine, Chicago, Illinois.
ORCID-Profile: Erica L MacKenzie, Allison H Bartlett, Jessica P Ridgway
Zitieren
APA
MacKenzie, E. L., Murillo, C., Bartlett, A. H., Marrs, R., Landon, E. M., & Ridgway, J. P. (2023). Clostridioides difficile colonization and the frequency of subsequent treatment for C. difficile infection in critically ill patients. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2022.240
Vancouver
MacKenzie EL, Murillo C, Bartlett AH, Marrs R, Landon EM, Ridgway JP. Clostridioides difficile colonization and the frequency of subsequent treatment for C. difficile infection in critically ill patients. Infection Control & Hospital Epidemiology. 2023. doi:10.1017/ice.2022.240
BibTeX
@article{MacKenzie2023,
author = {MacKenzie, Erica L and Murillo, Cynthia and Bartlett, Allison H and Marrs, Rachel and Landon, Emily M and Ridgway, Jessica P},
title = {Clostridioides difficile colonization and the frequency of subsequent treatment for C. difficile infection in critically ill patients},
journal = {Infection Control & Hospital Epidemiology},
year = {2023},
doi = {10.1017/ice.2022.240}
}
EUVIMED